Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3 Double-masked, Randomized, Multicenter Study of the Efficacy and Safety of OCS 01 Eye Drops in Subjects With Diabetic Macular Edema

NCT06172257 is registered in ClinicalTrials.gov with Oculis as lead sponsor.

NCT NCT06172257
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06172257 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3 Double-masked, Randomized, Multicenter Study of the Efficacy and Safety of OCS 01 Eye Drops in Subjects With Diabetic Macular Edema
Lead sponsor
Oculis
Phase
Phase 3
Overall status
Completed
Start date
March 15, 2024
Completion date
April 2, 2026
Enrollment
401 (actual)
Sites
62

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic macular edema